Supriya Lifescience Limited — Results, 13-03-2026: Reply to Clarification- Financial results

Company clarified segment details in earlier results. The absence of segment information was due to a technical error. They operate solely in the Pharmaceuticals segment, and this clarification does not affect previously reported financial figures or their interpretation.